Eledon Pharmaceuticals (ELDN) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.35% |
| Dec 31, 2025 | -8.36% |
| Sep 30, 2025 | -91.58% |
| Jun 30, 2025 | -42.44% |
| Mar 31, 2025 | -48.86% |
| Dec 31, 2024 | -56.49% |
| Sep 30, 2024 | -32.43% |
| Jun 30, 2024 | -9.57% |
| Mar 31, 2024 | -16.79% |
| Dec 31, 2023 | -22.18% |
| Sep 30, 2023 | -33.08% |
| Jun 30, 2023 | -19.78% |
| Mar 31, 2023 | -34.31% |
| Dec 31, 2022 | -29.42% |
| Sep 30, 2022 | -5.99% |
| Jun 30, 2022 | 4.99% |
| Mar 31, 2022 | -56.03% |
| Dec 31, 2021 | -48.41% |
| Sep 30, 2021 | -36.79% |
| Jun 30, 2021 | -24.42% |
| Mar 31, 2021 | 11.94% |
| Dec 31, 2020 | -0.74% |
| Sep 30, 2020 | 44.24% |
| Jun 30, 2020 | 22.99% |
| Mar 31, 2020 | 27.74% |
| Dec 31, 2019 | 20.72% |
| Sep 30, 2019 | 8.36% |
| Jun 30, 2019 | 1.93% |
| Mar 31, 2019 | 3.42% |
| Dec 31, 2018 | 13.25% |